Cantuzumab

• Target:

  ADC Antibody

• Related Pathways:

  Antibody-drug Conjugate/ADC Related

• Purity:

  0.9976

• Bioactivity:

  Cantuzumab is a monoclonal antibody targeting the CanAg antigen with anti-tumor activity, used in the synthesis of the ADC compound cantuzumab mertansine.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  1204740-23-7